The Asia Preimplantation Genetic Diagnosis (PGD) Market has shown remarkable growth, with a valuation of USD 457 billion in 2022. Forecasts predict it will further surge to USD 1101.16 billion by 2032, exhibiting a revenue CAGR of 11% during the projected period. The steady expansion of Asia's PGD market is attributed to a 10.6% revenue CAGR, primarily fueled by the increasing prevalence of genetic abnormalities and growing public awareness of PGD.
https://www.reportsanddata.com..../report-detail/asia-
Curtir
Comentario
Compartilhar
